Showing 1–6 of 6 results
-
Amendments and Corrections | | Open
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness
- Harriett Holme
- , Aditi Gulati
- , Rachel Brough
- , Emmy D. G. Fleuren
- , Ilirjana Bajrami
- , James Campbell
- , Irene Y. Chong
- , Sara Costa-Cabral
- , Richard Elliott
- , Tim Fenton
- , Jessica Frankum
- , Samuel E. Jones
- , Malini Menon
- , Rowan Miller
- , Helen N. Pemberton
- , Sophie Postel-Vinay
- , Rumana Rafiq
- , Joanna L. Selfe
- , Alex von Kriegsheim
- , Amaya Garcia Munoz
- , Javier Rodriguez
- , Janet Shipley
- , Winette T. A. van der Graaf
- , Chris T. Williamson
- , Colm J. Ryan
- , Stephen Pettitt
- , Alan Ashworth
- , Sandra J. Strauss
- & Christopher J. Lord
-
Research | | Open
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness
- Harriett Holme
- , Aditi Gulati
- , Rachel Brough
- , Emmy D. G. Fleuren
- , Ilirjana Bajrami
- , James Campbell
- , Irene Y. Chong
- , Sara Costa-Cabral
- , Richard Elliott
- , Tim Fenton
- , Jessica Frankum
- , Samuel E. Jones
- , Malini Menon
- , Rowan Miller
- , Helen N. Pemberton
- , Sophie Postel-Vinay
- , Rumana Rafiq
- , Joanna L. Selfe
- , Alex von Kriegsheim
- , Amaya Garcia Munoz
- , Javier Rodriguez
- , Janet Shipley
- , Winette T. A. van der Graaf
- , Chris T. Williamson
- , Colm J. Ryan
- , Stephen Pettitt
- , Alan Ashworth
- , Sandra J. Strauss
- & Christopher J. Lord
-
Research | | Open
Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells
- Stephen J. Pettitt
- , Dragomir B. Krastev
- , Helen N. Pemberton
- , Yari Fontebasso
- , Jessica Frankum
- , Farah L. Rehman
- , Rachel Brough
- , Feifei Song
- , Ilirjana Bajrami
- , Rumana Rafiq
- , Fredrik Wallberg
- , Iwanka Kozarewa
- , Kerry Fenwick
- , Javier Armisen-Garrido
- , Amanda Swain
- , Aditi Gulati
- , James Campbell
- , Alan Ashworth
- & Christopher J. Lord
-
Research | | Open
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors
- Malini Menon
- , Richard Elliott
- , Leandra Bowers
- , Nicolae Balan
- , Rumana Rafiq
- , Sara Costa-Cabral
- , Felix Munkonge
- , Ines Trinidade
- , Roderick Porter
- , Andrew D. Campbell
- , Emma R. Johnson
- , Christina Esdar
- , Hans-Peter Buchstaller
- , Birgitta Leuthner
- , Felix Rohdich
- , Richard Schneider
- , Owen Sansom
- , Dirk Wienke
- , Alan Ashworth
- & Christopher J. Lord
-
Research | | Open
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
- Stephen J. Pettitt
- , Dragomir B. Krastev
- , Inger Brandsma
- , Amy Dréan
- , Feifei Song
- , Radoslav Aleksandrov
- , Maria I. Harrell
- , Malini Menon
- , Rachel Brough
- , James Campbell
- , Jessica Frankum
- , Michael Ranes
- , Helen N. Pemberton
- , Rumana Rafiq
- , Kerry Fenwick
- , Amanda Swain
- , Sebastian Guettler
- , Jung-Min Lee
- , Elizabeth M. Swisher
- , Stoyno Stoynov
- , Kosuke Yusa
- , Alan Ashworth
- & Christopher J. Lord
-
Research | | Open
